Requirement of NOX2 expression in both retina and bone marrow for diabetes-induced retinal vascular injury

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Rojas, Modesto ^a,b   Zhang, Wenbo ^a,b,c   Xu, Zhimin ^a,b   Lemtalsi, Tahira ^a,b   Chandler, Phillip ^b   Toque, Haroldo A ^b   Caldwell, Robert W ^b   Caldwell, Ruth B ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

^c University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL INJURY; BLOOD VESSEL PERMEABILITY; BONE MARROW CELL; CHIMERA; CONTROLLED STUDY; DIABETIC RETINOPATHY; ENZYME ACTIVITY; ENZYME DEFICIENCY; ENZYME LOCALIZATION; FEMUR; INSULIN DEPENDENT DIABETES MELLITUS; LEUKOCYTE ADHERENCE; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; RETINA BLOOD VESSEL; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; TIBIA;

ANIMALS; ANTIGENS, CD45; BLOOD-RETINAL BARRIER; BONE MARROW; CELL ADHESION; CHIMERA; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC RETINOPATHY; GENE EXPRESSION; GENOTYPE; INTERCELLULAR ADHESION MOLECULE-1; LEUKOCYTES; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, KNOCKOUT; NADPH OXIDASE; OXIDATIVE STRESS; PEROXYNITROUS ACID; RETINA; TYROSINE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84892910910     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0084357     Document Type: Article

References (41)

1. Sivaprasad S, Gupta B, Crosby-Nwaobi R, Evans J (2012) Prevalence of diabetic retinopathy in various ethnic groups: a worldwide perspective. Surv Ophthalmol 57: 347-370. doi:10.1016/j.survophthal.2012.01.004. PubMed: 22542913.
2. Zhang X, Saaddine JB, Chou CF, Cotch MF, Cheng YJ et al. (2010) Prevalence of diabetic retinopathy in the United States, 2005-2008. JAMA 304: 649-656. doi:10.1001/jama.2010.1111. PubMed: 20699456.
3. Klein R, Klein BE, Moss SE, Cruickshanks KJ (1998) The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes. Ophthalmology 105: 1801-1815. doi:10.1016/S0161-6420(98)91020-X. PubMed: 9787347.
4. Antonetti DA, Barber AJ, Khin S, Lieth E, Tarbell JM et al. (1998) Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group. Diabetes 47: 1953-1959. doi:10.2337/diabetes.47.12.1953. PubMed: 9836530.
5. Abiko T, Abiko A, Clermont AC, Shoelson B, Horio N et al. (2003) Characterization of retinal leukostasis and hemodynamics in insulin resistance and diabetes: role of oxidants and protein kinase-C activation. Diabetes 52: 829-837. doi:10.2337/diabetes.52.3.829. PubMed: 12606527.
6. Al-Shabrawey M, Rojas M, Sanders T, Behzadian A, El-Remessy A et al. (2008) Role of NADPH oxidase in retinal vascular inflammation. Invest Ophthalmol Vis Sci 49: 3239-3244. doi:10.1167/iovs.08-1755. PubMed: 18378574.
7. Giacco F, Brownlee M (2010) Oxidative stress and diabetic complications. Circ Res 107: 1058-1070. doi:10.1161/CIRCRESAHA.110.223545. PubMed: 21030723.
8. Zheng L, Kern TS (2009) Role of nitric oxide, superoxide, peroxynitrite and PARP in diabetic retinopathy. Front Biosci 14: 3974-3987. PubMed: 19273327.
9. Santos JM, Mohammad G, Zhong Q, Kowluru RA (2011) Diabetic retinopathy, superoxide damage and antioxidants. Curr Pharm Biotechnol 12: 352-361. doi:10.2174/138920111794480507. PubMed: 20939803.
10. Alexandraki K, Piperi C, Kalofoutis C, Singh J, Alaveras A et al. (2006) Inflammatory process in type 2 diabetes: The role of cytokines. Ann N Y Acad Sci 1084: 89-117. doi:10.1196/annals.1372.039. PubMed: 17151295.
11. Adamis AP, Berman AJ (2008) Immunological mechanisms in the pathogenesis of diabetic retinopathy. Semin Immunopathol 30: 65-84. doi:10.1007/s00281-008- 0111-x. PubMed: 18340447.
12. Kim I, Moon SO, Kim SH, Kim HJ, Koh YS et al. (2001) Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and Eselectin through nuclear factor-kappa B activation in endothelial cells. J Biol Chem 276: 7614-7620. doi:10.1074/jbc.M009705200. PubMed: 11108718.
13. Miyamoto K, Khosrof S, Bursell SE, Moromizato Y, Aiello LP et al. (2000) Vascular endothelial growth factor (VEGF)-induced retinal vascular permeability is mediated by intercellular adhesion molecule-1 (ICAM-1). Am J Pathol 156: 1733-1739. doi:10.1016/S0002-9440(10)65044-4. PubMed: 10793084.
14. Joussen AM, Murata T, Tsujikawa A, Kirchhof B, Bursell SE et al. (2001) Leukocyte-mediated endothelial cell injury and death in the diabetic retina. Am J Pathol 158: 147-152. doi:10.1016/S0002-9440(10)63952-1. PubMed: 11141487.
15. Babior BM (2002) The leukocyte NADPH oxidase. Isr Med Assoc J 4: 1023-1024. PubMed: 12489496.
16. Zhang C, Yang J, Jennings LK (2004) Leukocyte-derived myeloperoxidase amplifies high-glucose - induced endothelial dysfunction through interaction with high-glucose - stimulated, vascular non - leukocyte-derived reactive oxygen species. Diabetes 53: 2950-2959. doi:10.2337/diabetes.53.11.2950. PubMed: 15504976.
17. Ellis EA, Grant MB, Murray FT, Wachowski MB, Guberski DL et al. (1998) Increased NADH oxidase activity in the retina of the BBZ/Wor diabetic rat. Free Radic Biol Med 24: 111-120. doi:10.1016/S0891-5849(97)00202-5. PubMed: 9436620.
18. Ellis EA, Guberski DL, Hutson B, Grant MB (2002) Time course of NADH oxidase, inducible nitric oxide synthase and peroxynitrite in diabetic retinopathy in the BBZ/WOR rat. Nitric Oxide 6: 295-304. doi:10.1006/niox.2001. 0419. PubMed: 12009847.
19. Jarajapu YP, Caballero S, Verma A, Nakagawa T, Lo MC et al. (2011) Blockade of NADPH oxidase restores vasoreparative function in diabetic CD34+ cells. Invest Ophthalmol Vis Sci 52: 5093-5104. doi:10.1167/iovs.10-70911. PubMed: 21676908.
20. Al-Shabrawey M, Bartoli M, El-Remessy AB, Ma G, Matragoon S et al. (2008) Role of NADPH oxidase and Stat3 in statin-mediated protection against diabetic retinopathy. Invest Ophthalmol Vis Sci 49: 3231-3238. doi:10.1167/iovs.08-1754. PubMed: 18378570.
21. Bedard K, Krause KH (2007) The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 87: 245-313. doi:10.1152/physrev.00044.2005. PubMed: 17237347.
22. Flaquer M, Franquesa M, Barquinero J, Lloberas N, Gutiérrez C et al. (2009) Bone marrow transplantation induces normoglycemia in a type 2 diabetes mellitus murine model. Transplant Proc 41: 2282-2285. doi:10.1016/j.transproceed.2009.06.034. PubMed: 19715898.
23. Rojas M, Zhang W, Lee DL, Romero MJ, Nguyen DT et al. (2010) Role of IL-6 in angiotensin II-induced retinal vascular inflammation. Invest Ophthalmol Vis Sci 51: 1709-1718. doi:10.1167/iovs.09-3375. PubMed: 19834028.
24. Zhang W, Baban B, Rojas M, Tofigh S, Virmani SK et al. (2009) Arginase activity mediates retinal inflammation in endotoxin-induced uveitis. Am J Pathol 175: 891-902. doi:10.2353/ajpath.2009.081115. PubMed: 19590038.
25. Ward JM (2010) Mouse Hematology: A Laboratory Manual by Michael P. McGarry, Cheryl A. Protheroe, and James J. Lee. Vet Pathol.
26. Huang X, Sun M, Li D, Liu J, Guo H et al. (2011) Augmented NADPH oxidase activity and p22phox expression in monocytes underlie oxidative stress of patients with type 2 diabetes mellitus. Diabetes Res Clin Pract 91: 371-380. doi:10.1016/j.diabres.2010.12.026. PubMed: 21237524.
27. El-Remessy AB, Abou-Mohamed G, Caldwell RW, Caldwell RB (2003) High glucose-induced tyrosine nitration in endothelial cells: role of eNOS uncoupling and aldose reductase activation. Invest Ophthalmol Vis Sci 44: 3135-3143. doi:10.1167/iovs.02-1022. PubMed: 12824263.
28. El-Remessy AB, Behzadian MA, Abou-Mohamed G, Franklin T, Caldwell RW et al. (2003) Experimental diabetes causes breakdown of the blood-retina barrier by a mechanism involving tyrosine nitration and increases in expression of vascular endothelial growth factor and urokinase plasminogen activator receptor. Am J Pathol 162: 1995-2004. doi:10.1016/S0002-9440(10)64332-5. PubMed: 12759255.
29. Platt DH, Bartoli M, El-Remessy AB, Al-Shabrawey M, Lemtalsi T et al. (2005) Peroxynitrite increases VEGF expression in vascular endothelial cells via STAT3. Free Radic Biol Med 39: 1353-1361. doi:10.1016/j.freeradbiomed.2005.06. 015. PubMed: 16257644.
30. Vinores SA, Derevjanik NL, Ozaki H, Okamoto N, Campochiaro PA (1999) Cellular mechanisms of blood-retinal barrier dysfunction in macular edema. Doc Ophthalmol 97: 217-228. doi:10.1023/A:1002136712070. PubMed: 10896335.
31. Wuensch T, Thilo F, Krueger K, Scholze A, Ristow M et al. (2010) High glucose-induced oxidative stress increases transient receptor potential channel expression in human monocytes. Diabetes 59: 844-849. doi:10.2337/db09-1100. PubMed: 20068131.
32. Banumathi E, Sheikpranbabu S, Haribalaganesh R, Gurunathan S (2010) PEDF prevents reactive oxygen species generation and retinal endothelial cell damage at high glucose levels. Exp Eye Res 90: 89-96. doi:10.1016/j.exer.2009.09.014. PubMed: 19837064.
33. Li G, Veenstra AA, Talahalli RR, Wang X, Gubitosi-Klug RA et al. (2012) Marrow-Derived Cells Regulate the Development of Early Diabetic Retinopathy and Tactile Allodynia in Mice. Diabetes 61: 3294-3303. PubMed: 22923475.
34. Schäfer A, Alp NJ, Cai S, Lygate CA, Neubauer S et al. (2004) Reduced vascular NO bioavailability in diabetes increases platelet activation in vivo. Arterioscler Thromb Vasc Biol 24: 1720-1726. doi:10.1161/01.ATV. 0000138072.76902.dd. PubMed: 15242858.
35. Romero MJ, Iddings JA, Platt DH, Ali MI, Cederbaum SD et al. (2012) Diabetes-induced vascular dysfunction involves arginase I. Am J Physiol Heart Circ Physiol 302: H159-H166. doi:10.1152/ajpheart.00774.2011. PubMed: 22058149.
36. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA (1990) Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci U S A 87: 1620-1624. doi:10.1073/pnas.87.4.1620. PubMed: 2154753.
37. Darley-Usmar V, Wiseman H, Halliwell B (1995) Nitric oxide and oxygen radicals: a question of balance. FEBS Lett 369: 131-135. doi:10.1016/0014- 5793(95)00764-Z. PubMed: 7649244.
38. Pacher P, Beckman JS, Liaudet L (2007) Nitric oxide and peroxynitrite in health and disease. Physiol Rev 87: 315-424. doi:10.1152/physrev.00029.2006. PubMed: 17237348.
39. Qaum T, Xu Q, Joussen AM, Clemens MW, Qin W et al. (2001) VEGF-initiated blood-retinal barrier breakdown in early diabetes. Invest Ophthalmol Vis Sci 42: 2408-2413. PubMed: 11527957.
40. Nicoletti VG, Nicoletti R, Ferrara N, Meli G, Reibaldi M et al. (2003) Diabetic patients and retinal proliferation: an evaluation of the role of vascular endothelial growth factor (VEGF). Exp Clin Endocrinol Diabetes 111: 209-214. doi:10.1055/s-2003-40465. PubMed: 12845559.
41. Hazra S, Jarajapu YP, Stepps V, Caballero S, Thinschmidt JS et al. (2013) Long-term type 1 diabetes influences haematopoietic stem cells by reducing vascular repair potential and increasing inflammatory monocyte generation in a murine model. Diabetologia 56: 644-653. doi:10.1007/s00125-012-2781-0. PubMed: 23192694.